FDA Warning Letter — HydraMed

Case 728282 — FEI 3044021141

The FDA took a Warning Letter action against HydraMed on Jun 8, 2026 (Denver, CO). The action was issued by CDER and concerns drugs products.

Action details

Facility
HydraMed
Date
Jun 8, 2026
Fiscal Year
2026
Product Type
Drugs
Center
CDER
Location
Denver, CO (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.